472 related articles for article (PubMed ID: 26261286)
21. Plant protein diet-induced hypoimmunity by affecting the spiral valve intestinal microbiota and bile acid enterohepatic circulation in Amur sturgeon (Acipenser schrenckii).
Wei HC; Xing SJ; Chen P; Wu XF; Gu X; Luo L; Liang XF; Xue M
Fish Shellfish Immunol; 2020 Nov; 106():421-430. PubMed ID: 32798694
[TBL] [Abstract][Full Text] [Related]
22. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis.
Jia W; Xie G; Jia W
Nat Rev Gastroenterol Hepatol; 2018 Feb; 15(2):111-128. PubMed ID: 29018272
[TBL] [Abstract][Full Text] [Related]
23. Bile Acids Activated Receptors in Inflammatory Bowel Disease.
Biagioli M; Marchianò S; Carino A; Di Giorgio C; Santucci L; Distrutti E; Fiorucci S
Cells; 2021 May; 10(6):. PubMed ID: 34064187
[TBL] [Abstract][Full Text] [Related]
24. Disease-Associated Changes in Bile Acid Profiles and Links to Altered Gut Microbiota.
Joyce SA; Gahan CG
Dig Dis; 2017; 35(3):169-177. PubMed ID: 28249284
[TBL] [Abstract][Full Text] [Related]
25. The influence of rosuvastatin on the gastrointestinal microbiota and host gene expression profiles.
Nolan JA; Skuse P; Govindarajan K; Patterson E; Konstantinidou N; Casey PG; MacSharry J; Shanahan F; Stanton C; Hill C; Cotter PD; Joyce SA; Gahan CGM
Am J Physiol Gastrointest Liver Physiol; 2017 May; 312(5):G488-G497. PubMed ID: 28209601
[TBL] [Abstract][Full Text] [Related]
26. The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5.
Baars A; Oosting A; Knol J; Garssen J; van Bergenhenegouwen J
Microorganisms; 2015 Oct; 3(4):641-66. PubMed ID: 27682110
[TBL] [Abstract][Full Text] [Related]
27. Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.
Han JL; Lin HL
World J Gastroenterol; 2014 Dec; 20(47):17737-45. PubMed ID: 25548472
[TBL] [Abstract][Full Text] [Related]
28. The effect of gut microbiota on drug metabolism.
Kang MJ; Kim HG; Kim JS; Oh DG; Um YJ; Seo CS; Han JW; Cho HJ; Kim GH; Jeong TC; Jeong HG
Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1295-308. PubMed ID: 24033282
[TBL] [Abstract][Full Text] [Related]
29. Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs.
Noh K; Kang YR; Nepal MR; Shakya R; Kang MJ; Kang W; Lee S; Jeong HG; Jeong TC
Arch Pharm Res; 2017 Dec; 40(12):1345-1355. PubMed ID: 29181640
[TBL] [Abstract][Full Text] [Related]
30. Antibiotics-induced depletion of mice microbiota induces changes in host serotonin biosynthesis and intestinal motility.
Ge X; Ding C; Zhao W; Xu L; Tian H; Gong J; Zhu M; Li J; Li N
J Transl Med; 2017 Jan; 15(1):13. PubMed ID: 28086815
[TBL] [Abstract][Full Text] [Related]
31. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.
Sayin SI; Wahlström A; Felin J; Jäntti S; Marschall HU; Bamberg K; Angelin B; Hyötyläinen T; Orešič M; Bäckhed F
Cell Metab; 2013 Feb; 17(2):225-35. PubMed ID: 23395169
[TBL] [Abstract][Full Text] [Related]
32. Inulin fibre promotes microbiota-derived bile acids and type 2 inflammation.
Arifuzzaman M; Won TH; Li TT; Yano H; Digumarthi S; Heras AF; Zhang W; Parkhurst CN; Kashyap S; Jin WB; Putzel GG; Tsou AM; Chu C; Wei Q; Grier A; ; Worgall S; Guo CJ; Schroeder FC; Artis D
Nature; 2022 Nov; 611(7936):578-584. PubMed ID: 36323778
[TBL] [Abstract][Full Text] [Related]
33. The gut microbiota and the metabolic health of the host.
Joyce SA; Gahan CG
Curr Opin Gastroenterol; 2014 Mar; 30(2):120-7. PubMed ID: 24468803
[TBL] [Abstract][Full Text] [Related]
34. Role of Gut Microbiota in Liver Disease.
Brenner DA; Paik YH; Schnabl B
J Clin Gastroenterol; 2015; 49 Suppl 1(0 1):S25-7. PubMed ID: 26447960
[TBL] [Abstract][Full Text] [Related]
35. Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease.
Gadaleta RM; van Mil SW; Oldenburg B; Siersema PD; Klomp LW; van Erpecum KJ
Biochim Biophys Acta; 2010 Jul; 1801(7):683-92. PubMed ID: 20399894
[TBL] [Abstract][Full Text] [Related]
36. Bile acids as metabolic regulators.
Li T; Chiang JY
Curr Opin Gastroenterol; 2015 Mar; 31(2):159-65. PubMed ID: 25584736
[TBL] [Abstract][Full Text] [Related]
37. Altered enterohepatic circulation of bile acids in Crohn's disease and their clinical significance: a new perspective.
Nolan JD; Johnston IM; Walters JR
Expert Rev Gastroenterol Hepatol; 2013 Jan; 7(1):49-56. PubMed ID: 23265149
[TBL] [Abstract][Full Text] [Related]
38. Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases.
Shi L; Jin L; Huang W
Cells; 2023 Jul; 12(14):. PubMed ID: 37508557
[TBL] [Abstract][Full Text] [Related]
39. Investigation of Host-Gut Microbiota Modulation of Therapeutic Outcome.
Yip LY; Chan EC
Drug Metab Dispos; 2015 Oct; 43(10):1619-31. PubMed ID: 25979259
[TBL] [Abstract][Full Text] [Related]
40. Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization.
Prawitt J; Caron S; Staels B
Trends Endocrinol Metab; 2014 May; 25(5):235-44. PubMed ID: 24731596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
